Sara Karl-Lusardi
Nurse Practitioner · Grand Rapids, MINPI 1053995944
Payments from drug & device makers
Across 315 payments — averaging $21.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- E.r. Squibb & Sons, L.L.C.$656
- Novartis$500
- Boehringer Ingelheim$455
- Merck$434
- Novo Nordisk$389
- plus $3K from 30 others
What the payments were for
- Travel & lodging$1,01015%
- Food & beverage$5,76785%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 14 | $1,378 |
| E.r. Squibb & Sons, L.L.C. | 37 | $656 |
| Novartis | 33 | $500 |
| Boehringer Ingelheim | 19 | $455 |
| Merck | 22 | $434 |
| Novo Nordisk | 23 | $389 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $381 |
| Johnson & Johnson | 22 | $309 |
| Bayer | 21 | $303 |
| AstraZeneca(2 entities) | 12 | $252 |
| Amgen | 11 | $197 |
| Boston Scientific | 9 | $191 |
| Alnylam Pharmaceuticals Inc. | 10 | $179 |
| Kowa Pharmaceuticals America, Inc. | 13 | $140 |
| Pfizer | 5 | $105 |
| Daiichi Sankyo Inc. | 4 | $87 |
| Inspire Medical Systems, Inc. | 2 | $78 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $77 |
| Bridgebio Pharma, Inc. | 4 | $75 |
| Lilly USA, LLC | 4 | $70 |
| CMP Pharma, Inc. | 3 | $59 |
| Esperion Therapeutics, Inc. | 3 | $51 |
| Lexicon Pharmaceuticals, Inc. | 3 | $47 |
| Bardy Diagnostics, Inc. | 3 | $45 |
| Scpharmaceuticals Inc. | 3 | $43 |
| Actelion Pharmaceuticals US, Inc. | 2 | $41 |
| CSL Behring | 2 | $38 |
| Amarin Pharma, Inc. | 2 | $35 |
| Cardiva Medical, Inc. | 1 | $35 |
| Chiesi USA, Inc. | 1 | $27 |
| Corcept Therapeutics | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Abiomed | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| Impulse Dynamics (USA) Inc. | 1 | $17 |
| Philips North America LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYMPLICITY G3$801
- CAMZYOS$125
How this compares
$6,797 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 122 | $165,310 |
| EntrestoSacubitril/Valsartan | 109 | $143,049 |
| XareltoRivaroxaban | 64 | $76,097 |
| JardianceEmpagliflozin | 46 | $67,405 |
| FarxigaDapagliflozin Propanediol | 57 | $51,849 |
| Repatha SureclickEvolocumab | 36 | $29,125 |
| BrilintaTicagrelor | 26 | $20,879 |
| Metoprolol Succinate | 406 | $10,536 |
| Icosapent Ethyl | 19 | $7,948 |
| Ranolazine ErRanolazine | 43 | $5,273 |
| Atorvastatin Calcium | 262 | $5,211 |
| Rosuvastatin Calcium | 187 | $4,650 |
| Ezetimibe | 134 | $4,576 |
| ClopidogrelClopidogrel Bisulfate | 166 | $3,424 |
| Losartan Potassium | 155 | $2,837 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $105 | $165,310122 claims |
| NovartisEntresto | $500 | $143,049109 claims |
| Johnson & JohnsonXarelto | $309 | $76,09764 claims |
| AstraZenecaFarxiga, Brilinta | $252 | $72,72883 claims |
| Boehringer IngelheimJardiance | $455 | $67,40546 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Grand Rapids
- Debra DegraffGrand Rapids$80K
- Aaron EmmonsGrand Rapids$29K
- Natasha PeoplesGrand Rapids$12K
- Davida KrugerDetroit$1.8M
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.